Literature DB >> 18433992

Myeloid-derived suppressor cell role in tumor-related inflammation.

Luigi Dolcetti1, Ilaria Marigo, Barbara Mantelli, Elisa Peranzoni, Paola Zanovello, Vincenzo Bronte.   

Abstract

Chronic inflammatory state can create a proper environment for neoplastic onset and sustain cancer growth. The inflammatory state that arises at the tumor edge could contribute to immune escape phenomena in many ways. Myeloid-derived suppressor cells (MDSCs), a cell population that contributes to tumor escape, immune tolerance, and suppression, respond to a variety of pro-inflammatory and anti-inflammatory stimuli, which drive their recruitment and activation. Understanding how the inflammatory milieu favours tumor escape through the accumulation of MDSCs could be very useful to improve the efficacy of cancer immunotherapy.

Entities:  

Mesh:

Year:  2008        PMID: 18433992     DOI: 10.1016/j.canlet.2008.03.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  41 in total

1.  Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.

Authors:  Yuelong Liu; Xiaoyu Xiang; Xiaoying Zhuang; Shuangyin Zhang; Cunren Liu; Ziqiang Cheng; Sue Michalek; William Grizzle; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 2.  Dual roles for immunity in gastrointestinal cancers.

Authors:  Cristina Ferrone; Glenn Dranoff
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 3.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis.

Authors:  Catherine E Steding; Sung-tse Wu; Yanping Zhang; Meei-Huey Jeng; Bennett D Elzey; Chinghai Kao
Journal:  Immunology       Date:  2011-04-01       Impact factor: 7.397

5.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

Review 6.  Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.

Authors:  Peng Qu; Li-Zhen Wang; P Charles Lin
Journal:  Cancer Lett       Date:  2015-10-28       Impact factor: 8.679

7.  Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.

Authors:  Güllü Topal Görgün; Gregory Whitehill; Jennifer L Anderson; Teru Hideshima; Craig Maguire; Jacob Laubach; Noopur Raje; Nikhil C Munshi; Paul G Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

8.  Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Authors:  Venkatesh L Hegde; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

9.  Progressive growth of a murine T cell lymphoma alters population kinetics and cell viability of macrophages in a tumor-bearing host.

Authors:  Pramod K Gautam; Babu N Maurya; Sanjay Kumar; Praveen Deepak; Sanjay Kumar; Munendra S Tomar; Arbind Acharya
Journal:  Tumour Biol       Date:  2012-12-18

10.  Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination.

Authors:  Chi-Mu Chuang; Archana Monie; Chien-Fu Hung; T-C Wu
Journal:  J Biomed Sci       Date:  2010-04-28       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.